- Home
- HOFT vs BDTX Comparison
HOFT vs BDTX Comparison
Compare HOFT & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HOFT | BDTX |
|---|---|---|
| Founded | 1924 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 144.6M | 116.8M |
| IPO Year | 1999 | 2020 |
Fundamental Metrics
Financial Performance| Metric | HOFT | BDTX |
|---|---|---|
| Price | $12.34 | $2.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $9.67 |
| AVG Volume (30 Days) | 35.8K | ★ 827.9K |
| Earning Date | 04-16-2026 | 05-08-2026 |
| Dividend Yield | ★ 3.79% | N/A |
| EPS Growth | N/A | ★ 130.71 |
| EPS | N/A | ★ 0.39 |
| Revenue | ★ $278,139,000.00 | N/A |
| Revenue This Year | $17.37 | N/A |
| Revenue Next Year | $9.00 | N/A |
| P/E Ratio | ★ N/A | $6.58 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.46 | $1.46 |
| 52 Week High | $15.99 | $4.94 |
Technical Indicators
Market Signals| Indicator | HOFT | BDTX |
|---|---|---|
| Relative Strength Index (RSI) | 42.08 | 48.80 |
| Support Level | $12.15 | $2.45 |
| Resistance Level | $13.47 | $2.79 |
| Average True Range (ATR) | 0.88 | 0.20 |
| MACD | -0.16 | -0.05 |
| Stochastic Oscillator | 13.65 | 14.84 |
Price Performance
Historical ComparisonAbout HOFT Hooker Furnishings Corporation
Hooker Furnishings Corp is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segment Hooker Branded segment, Home Meridian segment, Domestic Upholstery segment and All Other.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.